Adient plc ADNT
16.22 USD -0.14 (-0.86%)
Nov 10, 2026, 11:08 AM EST
16.05 Day range 16.57
15.80 52-week range 27.32
- YTD
- -15.39%
- 1 year
- -17.75%
News
zacks.com New Strong Sell Stocks for November 10th ADNT, DOX and CDE have been added to the Zacks Rank #5 (Strong Sell) List on November 10, 2026.
benzinga.com Citigroup Maintains Buy on Adient, Lowers Price Target to $27 Citigroup analyst Michael Ward maintains Adient (NYSE:ADNT) with a Buy and lowers the price target from $29 to $27.
benzinga.com JP Morgan Maintains Overweight on Adient, Lowers Price Target to $23 JP Morgan analyst Rajat Gupta maintains Adient (NYSE:ADNT) with a Overweight and lowers the price target from $25 to $23.
defenseworld.net Traders Buy Large Volume of Adient Call Options (NYSE:ADNT) Adient (NYSE: ADNT - Get Free Report) saw unusually large options trading on Tuesday. Traders acquired 4,241 call options on the stock. This is an increase of 1,098% compared to the average daily…
marketbeat.com Adient Q4 Earnings Call Highlights Adient NYSE: ADNT expects higher adjusted earnings in fiscal 2027 despite declining vehicle production and lower sales, as the automotive seating supplier relies on cost reductions and recoveries…
seekingalpha.com Adient plc (ADNT) Q4 2026 Earnings Call Transcript Adient plc (ADNT) Q4 2026 Earnings Call Transcript
zacks.com Compared to Estimates, Adient (ADNT) Q4 Earnings: A Look at Key Metrics Although the revenue and EPS for Adient (ADNT) give a sense of how its business performed in the quarter ended September 2026, it might be worth considering how some key metrics compare with Wall…
benzinga.com Adient Q4 2026 Earnings Call Transcript Adient (NYSE:ADNT) reported fourth-quarter financial results on Wednesday. The transcript from the company’s fourth-quarter earnings call has been provided below.This transcript is brought to you by…
zacks.com Adient (ADNT) Q4 Earnings Miss Estimates Adient (ADNT) came out with quarterly earnings of $0.52 per share, missing the Zacks Consensus Estimate of $0.63 per share. This compares to earnings of $0.52 per share a year ago.
benzinga.com Adient Announces $400M Stock Buyback Increase To Total Authorization Of $1B, With $435M Remaining Company's share repurchase authorization and adopted a Tax Benefits Preservation Plan intended to protect the value of Adient's significant U.S. tax attributes for the benefit of all shareholders.The…
prnewswire.com Adient announces increased share repurchase authorization and adoption of tax benefits preservation plan PLYMOUTH, Mich., Nov. 4, 2026 /PRNewswire/ -- Adient (NYSE: ADNT), a global leader in automotive seating, today announced that its Board of Directors has approved an increase to the company's share…
benzinga.com Adient Q4 Adj. EPS $0.52 Misses $0.58 Estimate, Sales $3.730B Beat $3.604B Estimate Adient (NYSE:ADNT) reported quarterly earnings of $0.52 per share which missed the analyst consensus estimate of $0.58 by 10.34 percent. This is unchanged from the same period last year. The company…
prnewswire.com Adient reports fourth quarter and full-year 2026 results, including full-year FCF of $222M PLYMOUTH, Mich., Nov. 4, 2026 /PRNewswire/ -- Adient (NYSE: ADNT), a global leader in automotive seating, today announced its fourth quarter 2026 financial results and provided FY 2027 outlook.
benzinga.com Barclays Maintains Equal-Weight on Adient, Lowers Price Target to $22 Barclays analyst Dan Levy maintains Adient (NYSE:ADNT) with a Equal-Weight and lowers the price target from $25 to $22.
benzinga.com Adient Q3 2026 Earnings Call Transcript Adient (NYSE:ADNT) released third-quarter financial results and hosted an earnings call on Wednesday. Read the complete transcript below. This transcript is brought to you by Benzinga APIs. For…- benzinga.com Adient Appoints EVP And CFO, Effective November 16, Succeeding Mark Oswald Adient (NYSE:ADNT), a global leader in automotive seating, today announced that on Oct. 1, 2026, Peter Carlin will be stepping down from Adient's board of directors and joining the company initially…
- benzinga.com JP Morgan Upgrades Adient to Overweight, Lowers Price Target to $25 JP Morgan analyst Rajat Gupta upgrades Adient (NYSE:ADNT) from Neutral to Overweight and lowers the price target from $28 to $25.
- benzinga.com Morgan Stanley Maintains Equal-Weight on Adient, Lowers Price Target to $21 Morgan Stanley analyst Andrew Percoco maintains Adient (NYSE:ADNT) with a Equal-Weight and lowers the price target from $22 to $21.
- benzinga.com Citigroup Maintains Buy on Adient, Lowers Price Target to $29 Citigroup analyst Michael Ward maintains Adient (NYSE:ADNT) with a Buy and lowers the price target from $33 to $29.
- benzinga.com JP Morgan Maintains Neutral on Adient, Raises Price Target to $28 JP Morgan analyst Rajat Gupta maintains Adient (NYSE:ADNT) with a Neutral and raises the price target from $26 to $28.
benzinga.com Barclays Maintains Equal-Weight on Adient, Lowers Price Target to $25 Barclays analyst Dan Levy maintains Adient (NYSE:ADNT) with a Equal-Weight and lowers the price target from $29 to $25.- benzinga.com Deutsche Bank Maintains Buy on Adient, Lowers Price Target to $29 Deutsche Bank analyst Edison Yu maintains Adient (NYSE:ADNT) with a Buy and lowers the price target from $31 to $29.
benzinga.com Wells Fargo Maintains Overweight on Adient, Raises Price Target to $32 Wells Fargo analyst Colin Langan maintains Adient (NYSE:ADNT) with a Overweight and raises the price target from $28 to $32.- benzinga.com Barclays Maintains Equal-Weight on Adient, Raises Price Target to $29 Barclays analyst Dan Levy maintains Adient (NYSE:ADNT) with a Equal-Weight and raises the price target from $26 to $29.
benzinga.com Earnings Scheduled For May 6, 2026 
benzinga.com Adient Q2 2026 Earnings Call: Complete Transcript 
benzinga.com 3 Cyclical Stocks to Buy For A Potential Summer Recovery 
benzinga.com Citigroup Upgrades Adient to Buy, Raises Price Target to $33 Citigroup analyst Michael Ward upgrades Adient (NYSE:ADNT) from Neutral to Buy and raises the price target from $30 to $33.- benzinga.com Wells Fargo Maintains Overweight on Adient, Lowers Price Target to $28 Wells Fargo analyst Colin Langan maintains Adient (NYSE:ADNT) with a Overweight and lowers the price target from $29 to $28.
benzinga.com Barclays Maintains Equal-Weight on Adient, Lowers Price Target to $26 Barclays analyst Dan Levy maintains Adient (NYSE:ADNT) with a Equal-Weight and lowers the price target from $27 to $26.
benzinga.com Zenas Biopharma, Daqo New Energy And Other Big Stocks Moving Lower In Friday's Pre-Market Session U.S. stock futures down, Zenas Biopharma shares fall 9.5% in pre-market trading due to pricing of public offerings. Other stocks also lower.- benzinga.com Citigroup Maintains Neutral on Adient, Raises Price Target to $30 Citigroup analyst Michael Ward maintains Adient (NYSE:ADNT) with a Neutral and raises the price target from $22.5 to $30.
- benzinga.com JP Morgan Maintains Neutral on Adient, Raises Price Target to $28 JP Morgan analyst Ryan Brinkman maintains Adient (NYSE:ADNT) with a Neutral and raises the price target from $24 to $28.
- benzinga.com Barclays Maintains Equal-Weight on Adient, Raises Price Target to $27 Barclays analyst Dan Levy maintains Adient (NYSE:ADNT) with a Equal-Weight and raises the price target from $25 to $27.
benzinga.com Demystifying Adient: Insights From 8 Analyst Reviews - benzinga.com Morgan Stanley Maintains Equal-Weight on Adient, Raises Price Target to $22 Morgan Stanley analyst Andrew Percoco maintains Adient (NYSE:ADNT) with a Equal-Weight and raises the price target from $20 to $22.
benzinga.com 8 Consumer Discretionary Stocks Moving In Wednesday's Intraday Session 
benzinga.com Adient Q1 Earnings Summary & Key Takeaways 
benzinga.com Earnings Breakdown: Adient Q1 
benzinga.com Earnings Summary: Adient Q1 - benzinga.com Insights into Adient Q1 Earnings
- benzinga.com Adient Q1 Earnings Report: What Investors Need to Know
- benzinga.com Adient Q1 Earnings Assessment
- benzinga.com Adient: Q1 Earnings Insights
benzinga.com Adient Q1 Sales $3.644B Beat $3.515B Estimate Adient (NYSE:ADNT) reported quarterly earnings of $0.35 per share which beat the analyst consensus estimate of $0.22 by 57.66 percent. This is a 29.63 percent increase over earnings of $0.27 per…- benzinga.com Earnings Scheduled For February 4, 2026
benzinga.com TG Therapeutics, Clover Health Investments, Nutrien And Other Big Stocks Moving Higher On Wednesday - benzinga.com 12 Consumer Discretionary Stocks Moving In Wednesday's Intraday Session
benzinga.com Earnings Scheduled For November 5, 2025 - benzinga.com Earnings Scheduled For August 6, 2025